Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa-Reference-Cited by-同舟云学术

Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa

Published:2013-03-01 Issue:3 Volume:17 Page:368-372
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Van Rie A.¹,Page-Shipp L.²,Hanrahan C. F.¹,Schnippel K.²,Dansey H.³,Bassett J.³,Clouse K.⁴,Scott L.⁵,Stevens W.⁶,Sanne I.⁷

Affiliation:

1. Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

2. Right to Care, Johannesburg, South Africa

3. Witkoppen Health and Welfare Centre, Johannesburg, South Africa

4. Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Clinical HIV Research Unit, Johannesburg, South Africa

5. Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

6. Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; National Health Laboratory Service, Johannesburg, South Africa

7. Right to Care, Johannesburg, South Africa; and Clinical HIV Research Unit, Johannesburg, South Africa

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings;The International Journal of Tuberculosis and Lung Disease;2023-05-01

2. Cost-effectiveness of GeneXpert Omni compared with GeneXpert MTB/Rif for point-of-care diagnosis of tuberculosis in a low-resource, high-burden setting in Eastern Uganda: a cost-effectiveness analysis based on decision analytical modelling;BMJ Open;2022-08

3. The role of 99mTc-ethambutol scintigraphy to diagnose pulmonary tuberculosis;The Journal of Infection in Developing Countries;2022-01-31

4. Costs and cost-effectiveness of Gene Xpert compared to smear microscopy for the diagnosis of pulmonary tuberculosis using real-world data from Arsi zone, Ethiopia;PLOS ONE;2021-10-25

5. Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review;PharmacoEconomics;2021-07-15